Product Description
This is a standard artemisinin-based combination therapy (ACT) antimalarial.
Artesunate is a fast-acting artemisinin derivative, rapidly clearing malaria parasites, reducing parasite load and relieving acute malaria symptoms quickly. Amodiaquine is a long-acting antimalarial agent that eliminates residual parasites, prevents relapse and slows the development of drug resistance.
The two ingredients work synergistically to achieve high cure rates, lower recurrence and protect against antimalarial drug resistance.
Indications
Treatment of uncomplicated malaria caused by Plasmodium falciparum and other susceptible Plasmodium species in adults.
Directions for Use
Oral use, swallow whole with clean water. Take strictly as prescribed by a physician or health professional. Complete the full treatment course; do not stop medication early.
Product Features
- Standard ACT fixed-dose combination
- Fast parasite clearance + long-lasting therapeutic effect
- High cure rate and low recurrence rate
- Effectively delays malaria drug resistance
- Convenient single-tablet combined therapy
Storage
Store sealed in a cool, dry place, protect from direct sunlight, high temperature and moisture.
Warnings
- Contraindicated in hypersensitivity to artesunate, amodiaquine or any excipients.
- Use with caution in patients with liver, kidney impairment and cardiac arrhythmia.
- Not recommended in first trimester pregnancy without medical supervision.
- May cause mild dizziness, nausea, headache; avoid driving after taking.
- Keep out of reach of children.
